Post‐embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1477-2574|17|12|1137-1144

ISSN： 1365-182x

Source： HPB, Vol.17, Iss.12, 2015-12, pp. : 1137-1144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 467-469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Tumor Lysis Syndrome after Transarterial Chemoembolization for Well-Differentiated Hepatocellular Carcinoma with Neuroendocrine Features

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 532-535

Karger

Access to resources Recommend Favorite

Target lesion response predicts survival of patients with hepatocellular carcinoma retreated with transarterial chemoembolization

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 36, Iss. 10, 2016-10 ,pp. : 1516-1524

John Wiley & Sons Inc

Access to resources Recommend Favorite

By  

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 4, 2015-08 ,pp. : 766-770

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Prediction of the Outcome Using Tumor Markers and mRECIST in Unresectable Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 317-330

Karger

Access to resources Recommend Favorite